{"id":9258,"date":"2026-02-16T15:09:40","date_gmt":"2026-02-16T20:09:40","guid":{"rendered":"https:\/\/www.curingheartdisease.com\/?p=9258"},"modified":"2026-07-16T10:54:33","modified_gmt":"2026-07-16T14:54:33","slug":"hebben-babys-statines-nodig","status":"publish","type":"post","link":"https:\/\/www.curingheartdisease.com\/nl\/do-babies-need-statins\/","title":{"rendered":"Hebben baby's statines nodig?"},"content":{"rendered":"

The Early Developmental Origins of Atherosclerosis: Lipid Trajectories, Pathobiological Determinants, and the Lifelong Burden of Cardiovascular Risk from Infancy<\/h3>\n

Introduction<\/h3>\n

The understanding of atherosclerotic cardiovascular disease (ASCVD) has undergone a profound transformation over the last century, shifting from a perceived inevitable consequence of aging to a recognized life-course metabolic progression that commences during fetal development and infancy.[1] While the clinical manifestations of disease, such as myocardial infarction, stroke, and peripheral vascular syndromes, typically emerge in middle or late adulthood, the silent incubation of these conditions spans decades.[2\u20134] This developmental paradigm is supported by longitudinal epidemiological cohorts and post-mortem investigations, which collectively indicate that the foundations of cardiovascular pathology are established in the earliest stages of human existence.[2\u20135] So do babies need statins? Let\u2019s see!<\/p>\n

\"\"<\/h3>\n

Physiological Trajectories of Plasma Lipids in the First Two Years of Life<\/h3>\n

The neonatal period and early infancy represent a phase of dramatic metabolic transition characterized by rapid physiological adaptation to extrauterine life. At birth, cholesterol concentrations in umbilical cord blood are substantially lower than those observed in adult populations.[6] However, these levels are highly dynamic and follow distinct trajectories during the first 24 months of life.<\/p>\n

Stepwise Increases and Achievement of Early Baseline Levels<\/h3>\n

Concentrations of atherogenic lipid traits\u2014including low-density lipoprotein cholesterol (LDL-C), non-HDL-C, apolipoprotein B, and lipoprotein(a)\u2014exhibit a consistent stepwise increase from birth through the first 16 months of life.[6] Data from the Copenhagen Baby Heart Study, incorporating 13,354 cord blood samples with longitudinal venous follow-up, demonstrate that by 14\u201316 months, total cholesterol and LDL-C concentrations approach steady-state levels similar to those observed in adulthood.[1,6]<\/p>\n

This observation suggests that the baseline lipid phenotype may be established far earlier than previously hypothesized, constituting a neglected resource for early cardiovascular risk identification.[1]<\/p>\n

Variability in Non-Atherogenic Traits<\/h3>\n

Not all lipid parameters follow a linear rise. Total cholesterol and triglycerides increase sharply in early infancy and subsequently stabilize, whereas HDL-C may rise initially and decline modestly during dietary transition from lipid-rich milk to mixed diets.[6] This variability reflects the metabolic plasticity of infancy as nutritional substrates shift.<\/p>\n

Normal Reference Values for Infants and Children<\/h3>\n

Because lipid levels change rapidly in early life, interpretation requires age-specific reference ranges.[6,7]<\/p>\n

Neonatal and Infantile Lipid Ranges (0\u201324 Months)<\/h3>\n

Lipid levels at birth are markedly lower than adult thresholds but rise rapidly during infancy, reaching near\u2013adult steady-state concentrations by 14\u201316 months.[1,6]<\/p>\n

Table 1. Neonatal and Infant Lipid Reference Values (Copenhagen Baby Heart Study)[6]<\/strong><\/p>\n\n\n\n\n\n\n\n
Age Group<\/strong><\/td>\nTotal Cholesterol (mg\/dL) Median (IQR)<\/strong><\/td>\nLDL-C (mg\/dL) Median (IQR)<\/strong><\/td>\nHDL-C (mg\/dL) Median (IQR)<\/strong><\/td>\nTriglycerides (mg\/dL) Median (IQR)<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Neonates (birth)<\/td>\n77 (70\u201393)<\/td>\n32 (24\u201339)<\/td>\n33 (27\u201341)<\/td>\n28 (24\u201334)<\/td>\n<\/tr>\n
Infancy (2 months)<\/td>\n147 (128\u2013166)<\/td>\n65 (52\u201379)<\/td>\n50 (41\u201362)<\/td>\n62 (48\u201384)<\/td>\n<\/tr>\n
Early toddler (14\u201316 months)<\/td>\n143 (124\u2013162)<\/td>\n84 (70\u2013103)<\/td>\n36 (30\u201345)<\/td>\n43 (30\u201360)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Note: Values reported in mmol\/L in Nielsen et al. and converted to mg\/dL.[6]<\/p>\n

Pediatric Lipid Classification (Ages 2\u201319 Years)<\/h3>\n

After age 2 years, lipid interpretation shifts from developmental physiology to cardiovascular risk thresholds. NHLBI pediatric guidelines define the following categories.[7]<\/p>\n

Table 2. Pediatric Lipid Classification Thresholds (2\u201319 Years)[7]<\/strong><\/p>\n\n\n\n\n\n\n\n
Classification<\/strong><\/td>\nTotal Cholesterol (mg\/dL)<\/strong><\/td>\nLDL-C (mg\/dL)<\/strong><\/td>\nHDL-C (mg\/dL)<\/strong><\/td>\nTriglycerides (mg\/dL)<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Acceptable<\/td>\n<170<\/td>\n<110<\/td>\n>45<\/td>\n<75 (0\u20139y) \/ <90 (10\u201319y)<\/td>\n<\/tr>\n
Borderline<\/td>\n170\u2013199<\/td>\n110\u2013129<\/td>\n40\u201345<\/td>\n75\u201399 (0\u20139y) \/ 90\u2013129 (10\u201319y)<\/td>\n<\/tr>\n
High\/Abnormal<\/td>\n\u2265200<\/td>\n\u2265130<\/td>\n<40<\/td>\n\u2265100 (0\u20139y) \/ \u2265130 (10\u201319y)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\"\"\"\"<\/h3>\n

Biological and Environmental Determinants of Infantile Lipid Levels<\/h3>\n

High cholesterol in infancy reflects a synthesis of biological maturity, genetic inheritance, and early environmental exposure.<\/p>\n

Biological Sex and Maternal Health<\/h3>\n

Female infants exhibit higher total cholesterol, LDL-C, and apoB concentrations than males, differences detectable from birth and persisting through early childhood.[1] Maternal hypercholesterolemia during pregnancy is associated with accelerated early atherogenesis in offspring.[8] Epigenetic analyses of fetal vascular tissue show altered epigenetic regulation of cholesterol-homeostasis pathways (including regulatory regions of SREBP2) in association with early fetal atherosclerotic lesions, supporting fetal metabolic imprinting as a mechanistic framework.[9]<\/p>\n

The Nutritional Paradox of Breastfeeding<\/h3>\n

Breastfed infants often show higher cholesterol concentrations than formula-fed peers, a physiologic response to the cholesterol-rich composition of human milk.[6] Early-life lipid exposure is consistent with lipid tracking across the life course.[10]<\/p>\n

Atherosclerosis in Infancy and Youth: Pathological Evidence<\/h3>\n

Atherosclerosis begins as fatty streaks\u2014subintimal accumulations of foam cells and lymphocytes\u2014that can be identified early in life.[2\u20134] Autopsy studies demonstrate that early lesions are detectable in infancy and become increasingly prevalent through childhood.[4,11,12]<\/p>\n

Pathobiological Determinants of Atherosclerosis in Youth (PDAY)<\/h3>\n

The PDAY study remains foundational in pediatric cardiovascular pathology. PDAY collected arterial specimens from 2,876 individuals aged 15\u201334 years who died of external causes.[2] Coronary and aortic lesions were present in adolescence, and lesion severity correlated strongly with modifiable risk factors.[2\u20134]<\/p>\n

Risk scoring derived from PDAY predicts later coronary artery calcification in adulthood, validating the clinical relevance of early-life risk burden.[13]<\/p>\n

Historical Trends in Pediatric Lipids<\/h3>\n

Mean total cholesterol levels among US youths declined between 1988 and 2010, with reductions in both mean levels and prevalence of elevated total cholesterol documented in NHANES analyses.[14] However, these improvements are counterbalanced by the obesity epidemic, which amplifies adverse lipid phenotypes in vulnerable subgroups.[7]<\/p>\n

Mechanisms of Age-Related Cholesterol Elevation<\/h3>\n

Plasma cholesterol rises with aging largely due to reduced fractional clearance of LDL particles.[15] Aging is associated with declining hepatic LDL receptor activity and altered endocrine regulation. Growth hormone influences bile acid synthesis through cholesterol 7\u03b1-hydroxylase activity, providing mechanistic links between senescence and dyslipidemia.[16]<\/p>\n

The Evolutionary Heritage of High Plasma Cholesterol<\/h3>\n

High circulating cholesterol, while harmful in modern environments of caloric abundance, may have conferred survival advantages in ancestral contexts characterized by nutritional scarcity and infectious burden.[17]<\/p>\n

Evolutionary Advantages<\/strong><\/p>\n

Energy Security. Genetic variants favoring higher circulating cholesterol may have supported energy storage and reproductive fitness during feast-famine cycles.[18]
\nImmune Modulation. Membrane cholesterol organizes lipid rafts that cluster antigen receptors on memory T cells, enhancing immune responsiveness.[19] HDL also binds and neutralizes bacterial toxins such as lipopolysaccharides during infection.[20]
\nEndocrine Readiness. Cholesterol is the obligate precursor for steroid hormone synthesis, including cortisol, and is essential for adrenal stress adaptation.[21]
\nAntagonistic Pleiotropy. Traits conferring early-life survival benefit may persist despite late-life cardiovascular costs.[17]<\/p>\n

The Lifelong Burden of Cumulative LDL Exposure<\/h3>\n

Cardiovascular risk reflects cumulative arterial exposure to atherogenic lipoproteins rather than single time-point measurements.[1,22] Genetic, epidemiologic, and clinical evidence establishes LDL-C as a causal driver of ASCVD, emphasizing the importance of early prevention.[22]<\/p>\n

Clinical Management and the Window of Opportunity<\/h3>\n

Universal lifestyle promotion and targeted screening are central to prevention. NHLBI guidelines recommend universal lipid screening at ages 9\u201311 years and earlier screening beginning at age 2 in high-risk families.[7]<\/p>\n

Universal Lifestyle Interventions<\/strong><\/p>\n

The Cardiovascular Health Integrated Lifestyle Diet (CHILD-1) provides the foundation of primordial prevention beginning in early childhood.[7]<\/p>\n

    \n
  • Exclusive breastfeeding when possible[6]<\/li>\n
  • Delaying solid foods until at least 4 months[7]<\/li>\n
  • Transition to reduced-fat dairy after 12 months in appropriate contexts[7]<\/li>\n
  • Total fat intake of ~25\u201330% of calories after age 2 with saturated fat limitation[7]<\/li>\n<\/ul>\n

    Pharmacologic therapy is reserved for older children with severe dyslipidemia, particularly familial hypercholesterolemia.[7]<\/p>\n

    Conclusion<\/h3>\n

    Atherosclerosis is a lifelong process beginning in fetal development and infancy. Early lipid trajectories establish cumulative exposure burdens that drive lesion progression from fatty streaks in childhood to fibrous plaques in adulthood.[2\u20134] Prevention must therefore begin early\u2014optimizing maternal health, identifying high-risk lipid phenotypes in infancy, and implementing primordial prevention during the developmental window when vascular injury remains minimal and modifiable.[1,7,8] Infants are not eligible for statin therapy at this time but there certainly are things the mother can do when pregnant and after birth to protect her child for years to come.<\/p>\n

    References<\/h3>\n
      \n
    1. Holven KB. Plasma cholesterol levels in infancy: a neglected resource.\u00a0Eur Heart J<\/i>. 2023;44(42):4419-4421. doi:10.1093\/eurheartj\/ehad558<\/li>\n
    2. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.\u00a0Arterioscler Thromb<\/i>. 1993;13(9):1291-1298. doi:10.1161\/01.atv.13.9.1291<\/li>\n
    3. McGill HC Jr, McMahan CA, Zieske AW, et al. Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth.\u00a0Circulation<\/i>. 2000;102(4):374-379. doi:10.1161\/01.cir.102.4.374<\/li>\n
    4. Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study.\u00a0JAMA<\/i>. 1999;281(8):727-735. doi:10.1001\/jama.281.8.727<\/li>\n
    5. Luca AC, David SG, David AG, et al. Atherosclerosis from Newborn to Adult-Epidemiology, Pathological Aspects, and Risk Factors.\u00a0Life (Basel)<\/i>. 2023;13(10):2056. Published 2023 Oct 14. doi:10.3390\/life13102056<\/li>\n
    6. Taageby Nielsen S, Mohr Lytsen R, Strandkj\u00e6r N, et al. Significance of lipids, lipoproteins, and apolipoproteins during the first 14-16 months of life.\u00a0Eur Heart J<\/i>. 2023;44(42):4408-4418. doi:10.1093\/eurheartj\/ehad547<\/li>\n
    7. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.\u00a0Pediatrics<\/i>. 2011;128 Suppl 5(Suppl 5):S213-S256. doi:10.1542\/peds.2009-2107C<\/li>\n
    8. Napoli C, Glass CK, Witztum JL, Deutsch R, D’Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study.\u00a0Lancet<\/i>. 1999;354(9186):1234-1241. doi:10.1016\/S0140-6736(99)02131-5<\/li>\n
    9. de Nigris F, Cacciatore F, Mancini FP, et al. Epigenetic Hallmarks of Fetal Early Atherosclerotic Lesions in Humans.\u00a0JAMA Cardiol<\/i>. 2018;3(12):1184-1191. doi:10.1001\/jamacardio.2018.3546<\/li>\n
    10. \u00d8yri LKL, Bogsrud MP, Kristiansen AL, et al. Cholesterol at ages 6, 12 and 24 months: Tracking and associations with diet and maternal cholesterol in the Infant Cholesterol Study.\u00a0Atherosclerosis<\/i>. 2021;326:11-16. doi:10.1016\/j.atherosclerosis.2021.04.017<\/li>\n
    11. Tanaka K, Masuda J, Imamura T, et al. A nation-wide study of atherosclerosis in infants, children and young adults in Japan.\u00a0Atherosclerosis<\/i>. 1988;72(2-3):143-156. doi:10.1016\/0021-9150(88)90075-5<\/li>\n
    12. Fran\u00e7oso LA, Coates V. Anatomicopathological evidence of the beginning of atherosclerosis in infancy and adolescence.\u00a0Arq Bras Cardiol<\/i>. 2002;78(1):131-142.<\/li>\n
    13. Gidding SS, Rana JS, Prendergast C, et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score in Young Adults Predicts Coronary Artery and Abdominal Aorta Calcium in Middle Age: The CARDIA Study.\u00a0Circulation<\/i>. 2016;133(2):139-146. doi:10.1161\/CIRCULATIONAHA.115.018042<\/li>\n
    14. Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010.\u00a0JAMA<\/i>. 2012;308(6):591-600. doi:10.1001\/jama.2012.9136<\/li>\n
    15. Ericsson S, Eriksson M, Vitols S, Einarsson K, Berglund L, Angelin B. Influence of age on the metabolism of plasma low density lipoproteins in healthy males.\u00a0J Clin Invest<\/i>. 1991;87(2):591-596. doi:10.1172\/JCI115034<\/li>\n
    16. Rudling M, Parini P, Angelin B. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.\u00a0J Clin Invest<\/i>. 1997;99(9):2239-2245. doi:10.1172\/JCI119398<\/li>\n
    17. Lea AJ, Clark AG, Dahl AW, et al. Applying an evolutionary mismatch framework to understand disease susceptibility.\u00a0PLoS Biol<\/i>. 2023;21(9):e3002311. Published 2023 Sep 11. doi:10.1371\/journal.pbio.3002311<\/li>\n
    18. Brassington L, Arner AM, Watowich MM, et al. Integrating the Thrifty Genotype and Evolutionary Mismatch Hypotheses to understand variation in cardiometabolic disease risk.\u00a0Evol Med Public Health<\/i>. 2024;12(1):214-226. Published 2024 Jul 31. doi:10.1093\/emph\/eoae014<\/li>\n
    19. Bietz A, Zhu H, Xue M, Xu C. Cholesterol Metabolism in T Cells.\u00a0Front Immunol<\/i>. 2017;8:1664. Published 2017 Nov 27. doi:10.3389\/fimmu.2017.01664<\/li>\n
    20. Meilhac O, Tanaka S, Couret D. High-Density Lipoproteins Are Bug Scavengers.\u00a0Biomolecules<\/i>. 2020;10(4):598. Published 2020 Apr 12. doi:10.3390\/biom10040598<\/li>\n
    21. Gomez-Sanchez CE, Gomez-Sanchez EP. Cholesterol Availability and Adrenal Steroidogenesis.\u00a0Endocrinology<\/i>. 2024;165(4):bqae032. doi:10.1210\/endocr\/bqae032<\/li>\n
    22. \u00a0<\/span>Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.\u00a0Eur Heart J<\/i>. 2017;38(32):2459-2472. doi:10.1093\/eurheartj\/ehx144<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

      Al tientallen jaren beschouwt het publiek hart- en vaatziekten als een \u201congeluk op latere leeftijd\u201d \u2013 een plotselinge botsing van leeftijd en leefstijl die toeslaat in de herfst van het leven. <\/p>","protected":false},"author":16,"featured_media":9226,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[219,220,225,226],"tags":[],"class_list":["post-9258","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lipids-medications-and-testing","category-medications-and-treatments","category-risk-genetics-special-populations","category-special-populations"],"acf":[],"yoast_head":"\nDo Babies Need Statins? - The Premiere Heart Health Education Platform<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curingheartdisease.com\/nl\/do-babies-need-statins\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Do Babies Need Statins? - The Premiere Heart Health Education Platform\" \/>\n<meta property=\"og:description\" content=\"For decades, the public has viewed heart disease as a \u201clate-life accident\u201d\u2014a sudden collision of age and lifestyle that strikes in the golden years.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curingheartdisease.com\/nl\/do-babies-need-statins\/\" \/>\n<meta property=\"og:site_name\" content=\"The Premiere Heart Health Education Platform\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/curingheartdisease\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-16T20:09:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-16T14:54:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/02\/post-image-31.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Peter Megdal PhD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RMHDInc\" \/>\n<meta name=\"twitter:site\" content=\"@RMHDInc\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Peter Megdal PhD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/\"},\"author\":{\"name\":\"Peter Megdal PhD\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\"},\"headline\":\"Do Babies Need Statins?\",\"datePublished\":\"2026-02-16T20:09:40+00:00\",\"dateModified\":\"2026-07-16T14:54:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/\"},\"wordCount\":1821,\"publisher\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/post-image-31.jpg\",\"articleSection\":[\"Lipids, Medications and Testing\",\"Medications and Treatments\",\"Risk, Genetics and Special Populations\",\"Special Populations\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/\",\"name\":\"Do Babies Need Statins? - The Premiere Heart Health Education Platform\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/post-image-31.jpg\",\"datePublished\":\"2026-02-16T20:09:40+00:00\",\"dateModified\":\"2026-07-16T14:54:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/post-image-31.jpg\",\"contentUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/post-image-31.jpg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/do-babies-need-statins\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Do Babies Need Statins?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#website\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\",\"name\":\"The Premiere Heart Health Education Platform\",\"description\":\"To make available to the public the state of the art information on how to reverse heart disease. This is an evidence-based organization utilizing the best available science, including diet, exercise drugs, and other resources to best fight this disease.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.curingheartdisease.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\",\"name\":\"Curing Heart Disease, LLC\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Curing-Heart-icon-red.png\",\"contentUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Curing-Heart-icon-red.png\",\"width\":512,\"height\":512,\"caption\":\"Curing Heart Disease, LLC\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/curingheartdisease\",\"https:\\\/\\\/x.com\\\/RMHDInc\",\"https:\\\/\\\/www.instagram.com\\\/rmhdinc\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCm8dh9c_D5RfJL7Z1f-yY4w\"],\"description\":\"Curing Heart Disease, LLC is an independent cardiovascular health education organization that publishes evidence-based articles, videos, podcasts, and educational tools about cardiovascular disease prevention, lipid science, nutrition, exercise, and related health topics.\",\"founder\":{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\"},\"foundingPerson\":{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\"},\"knowsAbout\":[\"Cardiovascular health\",\"Cardiovascular disease prevention\",\"Heart disease education\",\"Nutrition\",\"Exercise\",\"Lipid science\",\"Atherosclerosis\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/peters-story\\\/\",\"givenName\":\"Peter\",\"familyName\":\"Megdal\",\"honorificSuffix\":\"PhD\",\"jobTitle\":\"Nutrition Researcher and Cardiovascular Health Educator\",\"description\":\"Peter Megdal, PhD, is a nutrition researcher, cardiovascular health educator, published researcher, and longtime competitive cyclist. He earned a PhD in nutrition from the University of Massachusetts and publishes evidence-based cardiovascular health education through Curing Heart Disease.\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/peters-story\\\/\"},\"worksFor\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"affiliation\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"alumniOf\":{\"@type\":\"CollegeOrUniversity\",\"name\":\"University of Massachusetts\"},\"knowsAbout\":[\"Nutrition\",\"Cardiovascular health education\",\"Cardiovascular disease prevention\",\"Lipid science\",\"Exercise physiology\",\"Scientific research\"],\"sameAs\":[\"https:\\\/\\\/www.curingheartdisease.com\\\/author\\\/peter-megdal\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/peter-megdal-56075a2\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hebben baby's statines nodig? - Het vooraanstaande educatieve platform voor hartgezondheid","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curingheartdisease.com\/nl\/do-babies-need-statins\/","og_locale":"nl_NL","og_type":"article","og_title":"Do Babies Need Statins? - The Premiere Heart Health Education Platform","og_description":"For decades, the public has viewed heart disease as a \u201clate-life accident\u201d\u2014a sudden collision of age and lifestyle that strikes in the golden years.","og_url":"https:\/\/www.curingheartdisease.com\/nl\/do-babies-need-statins\/","og_site_name":"The Premiere Heart Health Education Platform","article_publisher":"https:\/\/www.facebook.com\/curingheartdisease","article_published_time":"2026-02-16T20:09:40+00:00","article_modified_time":"2026-07-16T14:54:33+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/02\/post-image-31.jpg","type":"image\/jpeg"}],"author":"Peter Megdal PhD","twitter_card":"summary_large_image","twitter_creator":"@RMHDInc","twitter_site":"@RMHDInc","twitter_misc":{"Geschreven door":"Peter Megdal PhD","Geschatte leestijd":"9 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/#article","isPartOf":{"@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/"},"author":{"name":"Peter Megdal PhD","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53"},"headline":"Do Babies Need Statins?","datePublished":"2026-02-16T20:09:40+00:00","dateModified":"2026-07-16T14:54:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/"},"wordCount":1821,"publisher":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/#primaryimage"},"thumbnailUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/02\/post-image-31.jpg","articleSection":["Lipids, Medications and Testing","Medications and Treatments","Risk, Genetics and Special Populations","Special Populations"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/","url":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/","name":"Hebben baby's statines nodig? - Het vooraanstaande educatieve platform voor hartgezondheid","isPartOf":{"@id":"https:\/\/www.curingheartdisease.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/#primaryimage"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/#primaryimage"},"thumbnailUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/02\/post-image-31.jpg","datePublished":"2026-02-16T20:09:40+00:00","dateModified":"2026-07-16T14:54:33+00:00","breadcrumb":{"@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/#primaryimage","url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/02\/post-image-31.jpg","contentUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/02\/post-image-31.jpg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.curingheartdisease.com\/do-babies-need-statins\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curingheartdisease.com\/"},{"@type":"ListItem","position":2,"name":"Do Babies Need Statins?"}]},{"@type":"WebSite","@id":"https:\/\/www.curingheartdisease.com\/#website","url":"https:\/\/www.curingheartdisease.com\/","name":"Het vooraanstaande educatieve platform voor hartgezondheid","description":"Het ter beschikking stellen aan het publiek van de meest geavanceerde informatie over het omkeren van hartaandoeningen. Dit is een op bewijs gebaseerde organisatie die gebruikmaakt van de best beschikbare wetenschap, waaronder voeding, beweging, medicijnen en andere middelen om deze ziekte zo goed mogelijk te bestrijden.","publisher":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curingheartdisease.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.curingheartdisease.com\/#organization","name":"Curing Heart Disease, LLC","url":"https:\/\/www.curingheartdisease.com\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/06\/cropped-Curing-Heart-icon-red.png","contentUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/06\/cropped-Curing-Heart-icon-red.png","width":512,"height":512,"caption":"Curing Heart Disease, LLC"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/curingheartdisease","https:\/\/x.com\/RMHDInc","https:\/\/www.instagram.com\/rmhdinc\/","https:\/\/www.youtube.com\/channel\/UCm8dh9c_D5RfJL7Z1f-yY4w"],"description":"Curing Heart Disease, LLC is een onafhankelijke organisatie voor voorlichting over cardiovasculaire gezondheid die op bewijs gebaseerde artikelen, video's, podcasts en educatieve hulpmiddelen publiceert over de preventie van hart- en vaatziekten, lipidenwetenschap, voeding, lichaamsbeweging en gerelateerde gezondheidsonderwerpen.","founder":{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD"},"foundingPerson":{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD"},"knowsAbout":["Cardiovascular health","Cardiovascular disease prevention","Heart disease education","Nutrition","Exercise","Lipid science","Atherosclerosis"]},{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD","url":"https:\/\/www.curingheartdisease.com\/peters-story\/","givenName":"Peter","familyName":"Megdal","honorificSuffix":"PhD","jobTitle":"Nutrition Researcher and Cardiovascular Health Educator","description":"Peter Megdal, PhD is voedingsonderzoeker, voorlichter op het gebied van hart- en vaatgezondheid, gepubliceerd onderzoeker en al jarenlang wedstrijdfietser. Hij behaalde een doctoraat in de voedingswetenschappen aan de Universiteit van Massachusetts en publiceert via Curing Heart Disease wetenschappelijk onderbouwde voorlichting over hart- en vaatgezondheid.","mainEntityOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/peters-story\/"},"worksFor":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"affiliation":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"alumniOf":{"@type":"CollegeOrUniversity","name":"University of Massachusetts"},"knowsAbout":["Nutrition","Cardiovascular health education","Cardiovascular disease prevention","Lipid science","Exercise physiology","Scientific research"],"sameAs":["https:\/\/www.curingheartdisease.com\/author\/peter-megdal\/","https:\/\/www.linkedin.com\/in\/peter-megdal-56075a2\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/posts\/9258","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/comments?post=9258"}],"version-history":[{"count":13,"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/posts\/9258\/revisions"}],"predecessor-version":[{"id":12105,"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/posts\/9258\/revisions\/12105"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/media\/9226"}],"wp:attachment":[{"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/media?parent=9258"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/categories?post=9258"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/nl\/wp-json\/wp\/v2\/tags?post=9258"}],"curies":[{"name":"goed gespeeld","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}